New ALS treatment showing promising results

Thanks! Share it with your friends!

You disliked this video. Thanks for the feedback!

Published Oct 6, 2022

The FDA approved Relyvrio Thursday with the goal of slowing down the deadly degenerative disease, amyotrophic lateral sclerosis.

Be the first to comment